Enanta Pharmaceuticals
ENTA
#8066
Rank
$0.36 B
Marketcap
$12.60
Share price
-3.08%
Change (1 day)
77.22%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -$51.49 Million USD

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are $69.21 Million USD. In 2025 the company made an earning of -$63.96 Million USD, an increase over its 2024 earnings that were of -$97.01 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$51.49 Million-19.49%
2025 -$63.96 Million-34.07%
2024 -$97.01 Million-23.87%
2023 -$0.13 Billion4.39%
2022 -$0.13 Billion-4.4%
2021 -$0.13 Billion91.12%
2020 -$66.81 Million-407.13%
2019 $21.75 M-78.63%
2018 $0.10 B117.97%
2017 $46.7 M-574.65%
2016 -$9.84 Million-110.83%
2015 $90.88 M-4.5%
2014 $95.16 M-638.53%
2013 -$17.68 Million-137.98%
2012 $46.52 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$25.97 B-50,556.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$15.78 B-30,755.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
$5.97 B-11,704.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$5.06 B-9,931.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$13.15 B-25,643.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$9.59 B-18,739.29%๐Ÿ‡บ๐Ÿ‡ธ USA